The Board of Directors of Pasithea Therapeutics Corp. has authorized a buyback plan on July 20, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.25 USD | +3.74% |
|
+5.63% | -29.05% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.05% | 5.28M | |
+15.70% | 121B | |
+19.86% | 113B | |
+17.47% | 26.02B | |
-25.22% | 19.39B | |
-19.51% | 15.91B | |
-19.10% | 15.09B | |
-46.87% | 15.06B | |
+63.61% | 14.93B | |
+5.77% | 13.85B |
- Stock Market
- Equities
- KTTA Stock
- News Pasithea Therapeutics Corp.
- Pasithea Therapeutics Corp. authorizes a Buyback Plan.